Indication
Chronic kidney disease associated with type 2 diabetes mellitus
Chronic kidney disease associated with type 2 diabetes mellitus is a progressive microvascular complication affecting the renal system in individuals with type 2 diabetes. Read more about Chronic kidney disease associated with type 2 diabetes mellitus
4 drugs 4 manufacturers
Drugs that treat it
Common Chronic kidney disease associated with type 2 diabetes mellitus therapies.
KERENDIA (finerenone)
INPEFA (sotagliflozin)
OZEMPIC (semaglutide)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonChronic kidney disease associated with type 2 diabetes mellitus is a progressive microvascular complication affecting the renal system in individuals with type 2 diabetes.
It is clinically characterized by persistent albuminuria, an elevated urinary albumin-to-creatinine ratio, or a sustained decline in estimated glomerular filtration rate present for at least three months.
Pathophysiologically, sustained hyperglycemia, metabolic dysregulation, and intraglomerular hypertension induce oxidative stress, chronic inflammation, and renal fibrosis, leading to glomerular basement membrane thickening and mesangial expansion.
If unaddressed, this progressive renal damage significantly elevates the risk of cardiovascular events, cardiovascular death, and end-stage kidney disease.
- mayoclinic.org
Chronic kidney disease associated with type 2 diabetes mellitus is a progressive microvascular complication affecting the renal system in individuals with type 2 diabetes If unaddressed, this progressive renal damage significantly elevates the risk of cardiovascular events, cardiovascular death, and end-stage kidney disease
- nih.gov
Chronic kidney disease associated with type 2 diabetes mellitus is a progressive microvascular complication affecting the renal system in individuals with type 2 diabetes If unaddressed, this progressive renal damage significantly elevates the risk of cardiovascular events, cardiovascular death, and end-stage kidney disease
- nih.gov
It is clinically characterized by persistent albuminuria, an elevated urinary albumin-to-creatinine ratio, or a sustained decline in estimated glomerular filtration rate present for at least three months Pathophysiologically, sustained hyperglycemia, metabolic dysregulation, and intraglomerular hypertension induce oxidative stress, chronic inflammation, and renal fibrosis, leading to glomerular basement membrane thickening and mesangial expansion
- diabetes.org
It is clinically characterized by persistent albuminuria, an elevated urinary albumin-to-creatinine ratio, or a sustained decline in estimated glomerular filtration rate present for at least three months If unaddressed, this progressive renal damage significantly elevates the risk of cardiovascular events, cardiovascular death, and end-stage kidney disease
- nih.gov
It is clinically characterized by persistent albuminuria, an elevated urinary albumin-to-creatinine ratio, or a sustained decline in estimated glomerular filtration rate present for at least three months
- medlineplus.gov
Pathophysiologically, sustained hyperglycemia, metabolic dysregulation, and intraglomerular hypertension induce oxidative stress, chronic inflammation, and renal fibrosis, leading to glomerular basement membrane thickening and mesangial expansion
- healthline.com
Pathophysiologically, sustained hyperglycemia, metabolic dysregulation, and intraglomerular hypertension induce oxidative stress, chronic inflammation, and renal fibrosis, leading to glomerular basement membrane thickening and mesangial expansion
Personalize your experience
Follow Chronic kidney disease associated with type 2 diabetes mellitus and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.